Imaging Biomarkers in Alzheimer
Alzheimer’s disease (AD) is a neurodegenerative disorder considered the most common cause of dementia worldwide. Dementia is a general term for the loss of cognitive…
QUIBIM made huge strides in
AI-powered diagnosis thanks to EU H2020
Taking part in the EU’s H2020 initiative translated into huge strides in disease detection and diagnosis by QUIBIM, by enabling the development of tools powered…
QUIBIM to develop platform in leading research project to fight pediatric cancer
QUIBIM is helping to advance knowledge of the most lethal pediatric tumors through EU-funded program PRIMAGE, which exploits precision information from medical imaging to establish…
IMAGING BIOMARKERS IN MULTIPLE SCLEROSIS
Pain, depression, slurred speech and feeling of numbness, tingling, or weakness. These are just some symptoms of Multiple Sclerosis (MS) disease, a long-term condition that…
QUIBIM’s AI-FUELED CHEST X-RAY CLASSIFIER GETS CE MARK
Chest X-ray classifier is added as a new CE cleared tool within QUIBIM Precision platform, which already received CE mark class IIa certification earlier in…
Our family keeps growing
We are proud to announce the incorporation of two new Quibimers in our growing team. Both excellent computer scientists, passionate about practising sport and named…